Medical, Health, & Pharmacy News Headlines

Pharmacy News Archives

Medical News Today
EurekAlert!
Univ. of Maryland
Medbroadcast.com
Reuters Health/Medical
New York Times Health
BBC Health & Medical
PRWeb Pharmaceuticals

Popular Medications

Weight Loss & Diet
Pain Relief
Men's Health
Women's Health
Skin Care
Quit Smoking
Sexual Health
Muscle Relaxants
Allergy Relief
Anti-depressants
Anxiety
Sleep Aids
Gastro-intestinal

Insurance & Litigation

Viatical Settlement

Tools & Information

Currency Converter
Resource Directory
Pharmacy Affiliate

 Back to PRWeb Archives



PRWeb: 12-28-2004

Ephedra Alternative May Be as Effective as Banned Ephedrine Diet Products but without the Risk
Retailers stock up on the only US patented alternative to Ephedra-based diet products to provide consumers with a safe alternative for their post-holidays weight loss resolutions. [PRWEB Dec 28, 2004]

RxDepot.biz Launches Online Pharmacy for Prescriptions and Medical Consultations
New site also offers a free monthly health newsletter with tips, coupons and discounts on prescription drugs. [PRWEB Dec 28, 2004]

Champagne – A History Of Celebration & Headaches
Perhaps the oldest of New Year's traditions, champagne has a history that rivals an episode of Desperate Housewives. Beloved by millions for centuries, champagne is also known to trigger headaches in many people. Recent breakthroughs in herbal research now point to a natural remedy that prevents and stops champagne headaches altogether -- just in time for 2005. [PRWEB Dec 27, 2004]

Alarmed Arthritis Sufferers Turning To Safe, Natural Pain-Relief Remedies - Holiday Season May Prove To Be More Uncomfortable For Millions
With recent news about another popular arthritis medication being pulled from distribution, many of the estimated 26 million arthritis sufferers worldwide are turning to safe, natural alternatives for relief from chronic pain. [PRWEB Dec 25, 2004]

MedicineNet Poll Shows Consumers Very Worried About Potential Side Effects of Naproxen (Aleve)
A MedicineNet consumer poll shows that 26.3% of health care consumers are very worried about potentially dangerous side effects, and 21.2% are not sure of what to believe [PRWEB Dec 24, 2004]

Avesthagen and Cipla Expand Scope of Collaboration
Pharma major Cipla and Bangalore based Avesthagen have expanded the scope of their ongoing biotherapeutics development programme. The expanded pipeline includes innovative next generation drugs that cater to the oncology and cardiovascular segments. [PRWEB Dec 24, 2004]

Ventria Bioscience Initiates Seventh Straight Year of Production
Plant-made pharmaceutical company developing health solutions for the global community. [PRWEB Dec 23, 2004]

Breast Augmentation Goes Au Naturel with Breast Enlargement Pills
Larger, Firmer Breasts with Breast Implants Plastic Surgery Alternative [PRWEB Dec 22, 2004]

Hot Peppers May Be a Natural Alternative To Dangerous COX Inhibitor Drugs
Recent headlines concerning anti-inflammatory drugs such as Vioxx, Celebrex, Bextra, and Naproxen are disconcerting for people suffering from chronic pain and arthritis. One research company says there may be a possible alternative that comes straight from “Mother Nature,” and the secret is found in hot peppers. [PRWEB Dec 22, 2004]

Euroscreen Enters Collaboration with Cephalon, Inc. to Discover GPCR-Directed Small Molecule Products
Euroscreen s.a. today announced a collaboration with Cephalon, Inc. to discover and develop small molecule therapeutics targeting G-Protein Coupled Receptors, or GPCR, a family of receptors that play a major role in cell signaling. The companies will apply Euroscreen’s AequoScreen™ proprietary functional assay technology in their efforts to generate novel small molecule leads across a broad range of GPCR targets. Under the terms of the agreement, Euroscreen will receive upfront and R&D payments with the potential for additional payments for successful programs. Euroscreen retains the right to aspects of the program that are not pursued by Cephalon in this collaboration. [PRWEB Dec 22, 2004]

Beasley Allen Law Firm Calls Upon Pfizer for Celebrex Recall
Experienced Celebrex attorneys have been reviewing patient cases against Pfizer since 2000. [PRWEB Dec 21, 2004]

DomainNesteggs.com Offers Tomorrow’s Healthcare Domain Names Today
If you go to your Internet connection today and type in HealthcareRobotics.com, you won’t be directed to a thriving Internet company that supplies robots to the healthcare industry. At the present, such a business doesn’t even exist. But that fact didn’t stop a farsighted Nashville futurist from registering 100 futuristic healthcare Internet domains earlier this year, and then listing them for sale at DomainNesteggs.com . [PRWEB Dec 21, 2004]

Board Certified Neurologist Embarks on Case Review and Scientific Literature Analysis of Vioxx, Celebrex and Naproxen for Legal Community
Kenneth Gross, M.D., who holds a Diplomate, American Board of Neurology and American Board of Internal Medicine, will perform a dual service for the Legal Community involved in assisting individuals potentially harmed by Vioxx, Celebrex or Naproxen. Dr. Gross will perform case reviews and a relevant scientific literature analysis in this regard. These drugs are implicated in higher rates of Stroke and/or Heart Attack in patients who have used them. [PRWEB Dec 21, 2004]

Research And Markets: Vast Range Of Companies In This Unique Drug Delivery Partnering Information Resource
Research and Markets (researchandmarkets.com/reports/c11265) has announced the addition of Drug Delivery Companies Report Autumn/Winter 2004 to their offering. [PRWEB Dec 21, 2004]

Nutritional Supplement NutriLife AR1 May be Answer for Cancer Patients
NutriLife AR1, an all-natural nutritional supplement, has shown documented improvement in patients with various forms of cancer and other types of illness when taken regularly. [PRWEB Dec 20, 2004]

Tiny Nasal Polyps can become a Huge Problem for Millions
More than half the population of the United States suffers from some form of chronic sinus and allergy problems affecting every aspect of their lives -- including sleep. One thing most of these sufferers have in common is an irritating growth known as "Nasal Polyps". Although polyps are traditionally treated with a combination of surgery and steroids, there may finally be an all natural remedy that beats them both. [PRWEB Dec 20, 2004]

All Natural FMG, Inc., Announces Its Topical Solution to Oral NSAIDs [Celebrex/Vioxx/Bextra]: IbuCream tm
Topical ibuprofen avoids problems associated with oral pain medications. [PRWEB Dec 20, 2004]

Intracellular Glutathione
The benefits provided by glutathione - Your immune system depends on your cells producing glutathione to aid in the prevention of all illnesses and diseases. [PRWEB Dec 17, 2004]

Xtalks Launches With a Bang - Inaugural Web Conference Stimulates Passionate Discussion on Drug Importation and Counterfeiting
Dr. Peter Rost of Pfizer and Eshetu Wondemagegnehu of the World Health Organization discussed different sides of the counterfeit drug debate addressing an international audience of senior pharmaceutical industry executives, policy makers and media reporters at a major conference on Anti-Counterfeiting Drug Strategies held by Xtalks (xtalks.com) on December 10. [PRWEB Dec 17, 2004]

Research And Markets: Are Electronic Prescriptions The Way Forward?
Research and Markets (researchandmarkets.com/reports/c11190) has announced the addition of Electronic Prescribing: Maintaining Leverage in the Future Prescribing Process to their offering. [PRWEB Dec 17, 2004]

Be Hangover Free this Holiday Season Even While Drinking at Holiday Parties
Holiday Party Hangovers? The secret your friends know to prevent a hangover before it starts. Don't suffer during the Holidays this year. Take these at your Christmas party and be hangover free. Visit (http://www.reboundhangoverformula.com) to learn more. [PRWEB Dec 16, 2004]

Modern Day Germs are Outsmarting Synthetic Medicine
We are approaching a time in which our dependence on what is natural, what is now a choice, will be our only option. [PRWEB Dec 14, 2004]

Research And Markets: Despite The Withdrawal Of Vioxx (Rofecoxib) From The Market In November 2004, Considerable Activity Continues To Be Reported Relating To The Development Of COX-2 Inhibitors.
[PRWEB Dec 14, 2004]

Hot Peppers May Put A Spicy End to Menstrual Headaches & Cramps
Although comedians get lots of material from Pre-menstrual Syndrome(PMS), a woman's menstruation cycle is no joke. American employers lose billions of dollars each year to lost productivity and increased sick time due to women suffering from bad menstrual cycles. Until recently, most women had no choice except to tough it out with only limited relief available, but modern science may have finally found a natural cure for women facing headaches and cramps. Amazingly, the secret is in nature's own hot peppers. [PRWEB Dec 13, 2004]

CPMP 2005 to Focus on Drug Development via Plant-Made Pharmaceuticals
Montreal Conference to Join Leaders in Drug Development and Discovery [PRWEB Dec 13, 2004]

Research And Markets - Falling Tag Prices: One Factor That Has Brought RFID Into The Spotlight
Research and Markets (researchandmarkets.com/reports/c10484) has announced the addition of RFID in healthcare to their offering. [PRWEB Dec 12, 2004]

Increased Number of Pharmaceutical Companies Has Been Using CROs to Accelerate the Development of New Drugs
Research and Markets(http://www.researchandmarkets.com/reports/c8629) has announced the addition of A Guide to Evaluating and Choosing CROs to their offering. [PRWEB Dec 12, 2004]

Soldiers Can Be Entrepreneurs Too - Setting Up Websites Is a Passion for One Airborne Soldier
A soldier from Ft. Polk has joined the ranks of becoming an online entrepreneur. He learned what it took by reading and attending seminars in his spare time. This week he lauched three websites selling gourmet Christmas gift baskets and tins, home security systems and even an online drugstore. [PRWEB Dec 11, 2004]

Synvisc Treatment Can Be Legally Imported from Canada
Synvisc - a common medical device used to treat osteoarthritis, can now be legally imported from Canada. Moreover, patients as well as doctors can save up to 50% on Synvisc if purchased from Canadian pharmacies. [PRWEB Dec 11, 2004]

New Drug Application Submitted to FDA for Intravenous Injection of Boniva: Would be First IV Bisphosphonate Treatment for Osteoporosis
Roche and GlaxoSmithKline (GSK) announced today the submission of a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for a novel intravenous (IV) injection formulation of its bisphosphonate Boniva (ibandronate sodium) for the treatment of postmenopausal osteoporosis. [PRWEB Dec 11, 2004]

© PR Web: Medical Pharmaceuticals